Search Orphan Drug Designations and Approvals
-
| Generic Name: | Adenovirus serotype-5 (Ad5) vector that contains a modified non-oncogenic fused early 6 (E6) and early 7 (E7) gene of the human papillomavirus (HPV); (Ad5 [E1-, E2b-]-E6/E7) |
|---|---|
| Date Designated: | 09/04/2014 |
| Orphan Designation: | Treatment of human papillomavirus (HPV)-associated head and neck squamous cell carcinoma (HNSCC) |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Etubics Corporation 410 West Harrison Street Suite 100 Seattle, Washington 98119 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







